Familial aggregation and clinical prognosis of hepatitis B virus infection in Guangzhou,China

Ye JunZhao; Wu YanQin; Li Rui; Li ShaoFeng; Zhong BiHui

doi:10.3969/j.issn.1001-5256.2016.07.018

Issue 7

Jul. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(7): 1305-1309

PDF( 1534 KB)

Familial aggregation and clinical prognosis of hepatitis B virus infection in Guangzhou,China

DOI: 10.3969/j.issn.1001-5256.2016.07.018

Research funding:

Published Date: 2016-07-20

Abstract

Abstract

Objective To investigate the characteristics of familial aggregation and prognosis of chronic hepatitis B( CHB) in Guangzhou,China,where there is a high prevalence of hepatitis B virus( HBV) infection. Methods The CHB patients who were treated in Outpatient Department of Hepatitis in the First Affiliated Hospital of Sun Yat- sen University from January 2009 to April 2016 were enrolled. The basic demographic features,relatives' HBV markers,patients' HBV indices,liver biochemical parameters,and findings on liver color Doppler ultrasound,computed tomography( CT),and magnetic resonance imaging( MRI) were analyzed. Familial aggregation was defined as at least two relatives diagnosed with chronic HBV infection,and the clinical features were compared between the groups with and without familial aggregation. The t- test was used for comparison of normally distributed continuous data between groups,and the Wilcoxon rank sum test was used for non- normally distributed continuous data between groups. The chi- square test or Fisher' s exact test was used for comparison of categorical data between groups. The univariate logistic regression was used to analyze familial aggregation and the risk factors for HBV infection,liver cirrhosis,and liver cancer in offspring. Results A total of 1096 CHB patients with a clear family history were enrolled; among these patients,569 had a positive family history,resulting in a rate of familial aggregation of 51. 9%. According to their age,the patients were stratified into groups of 16- 30 years,31- 45 years,and > 46 years. The proportions of patients diagnosed with liver cirrhosis across the three age stratifications in the groups with and without familial aggregation were 2. 1% /11. 5% /35. 6% and 2. 7% /5. 7% /38. 5%,respectively. The group with familial aggregation had a significantly higher proportion of patients aged 31- 45 years who were diagnosed with liver cirrhosis than the group without familial aggregation( χ2= 5. 71,P = 0. 02). The familial aggregation pattern was dominated by infection between siblings( 30. 2%) and mother- children infection( 34. 4%). Maternal and paternal infection( OR = 8. 18,95% CI: 5. 24-12. 75),maternal infection alone( OR = 4. 60,95% CI: 3. 69- 5. 74),and paternal infection alone( OR = 2. 77,95% CI: 2. 11- 3. 63)were associated with HBV infection in offspring. Familial aggregation pattern was not the risk factor for the development of liver cirrhosis in patients( P > 0. 05),while maternal and paternal infection( OR = 8. 5,P < 0. 01) was the risk factor for the development of liver cancer.Conclusion CHB infection shows high familial aggregation in Guangzhou,and the patients with a positive family history of CHB may progress to liver cirrhosis early.
- hepatitis B,
- chronic,
- familial aggregation

FullText(HTML)

References(13)

References

[1]SARIN SK,KUMAR M,LAU GK,et al.Asian-Pacific clinical practice guidelines on the management of hepatitis B:a 2015 update[J].Hepatol Int,2016,10(1):1-98.

[2]YANG Y,JIN L,HE YL,et al.Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China[J].J Med Virol,2013,85(11):1893-1899.

[3]ZHU B,RONG YH,LIU HL,et al.Clinical characteristics of hepatitis B virus-related acute-on-chronic liver failure patients with familial aggregation[J].Chin J Exp Clin Virol,2011,25(6):460-462.(in Chinese)朱冰,荣义辉,刘鸿凌,等.家族聚集性HBV相关慢加急性肝衰竭患者临床特点分析[J].中华实验和临床病毒学杂志,2011,25(6):460-462.

[4]YU MW,CHANG HC,CHEN PJ,et al.Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan[J].Int J Epidemiol,2002,31(5):1008-1015.

[5]GAO Y,JIANG Q,ZHOU X,et al.HBV infection and familial aggregation of liver cancer:an analysis of case-control family study[J].Cancer Causes Control,2004,15(8):845-850.

[6]SHAO FZ,SHI BA,LIU WQ,et al.The relationships among HBVgenotypes,HBV DNA levels and histopathological features in the livers of familial grouped hepatitis B patients in the Tianjin area[J].Chin J Hepatol,2007,15(1):16-18.(in Chinese)邵凤珍,施伯安,刘文全,等.天津地区家族聚集性慢性乙型肝炎病毒感染者病毒载量及组织病变与基因型的关系[J].中华肝脏病杂志,2007,15(1):16-18.

[7]PANG XH,WANG H,MA JX,et al.Study on family aggregation and risk factors of hepatitis B virus transmission in Chaoyang district,Beijing[J].Chin J Epidemibol,2012,46(9):818-821.(in Chinese)庞星火,王怀,马建新,等.北京市朝阳区乙型肝炎病毒感染家庭聚集性及传播危险因素研究[J].中华预防医学杂志,2012,46(9):818-821.

[8]GUPTA S,GUPTA R,JOSHI YK,et al.Role of horizontal transmission in hepatitis B virus spread among household contacts in north India[J].Intervirology,2008,51(1):7-13.

[9]ZENG XX,ZENG ZC,SUN LY,et al.Sero-epidemiological survey of hepatitis B virus infection in different populations in Hainan province[J].China Trop Med,2008,8(11):1894-1897,1905.(in Chinese)曾雪霞,曾昭长,孙莲英,等.海南省全国人群病毒性乙型肝炎血清流行病学调查[J].中国热带医学,2008,8(11):1894-1897,1905.

[10]LU W,ZHOU Y,XIE JX,et al.Epidemic survey of familial clustering risk factors for hepatitis B in Shanghai area[J].Acad J Second Military Med Univ,2009,30(10):1162-1165.(in Chinese)陆伟,周赟,谢佳新,等.上海地区乙型肝炎家庭聚集性危险因素的流行病学调查[J].第二军医大学学报,2009,30(10):1162-1165.

[11]LI J,LIU JY,HU JY,et al.Study on the status of HBV infection and its determinants among family members with HBV infected persons in Shanghai[J].Chin J Epidemiol,2013,34(3):205-209.(in Chinese)黎健,刘景壹,胡家瑜,等.上海市乙型肝炎感染者家庭成员感染状况及影响因素分析[J].中华流行病学杂志,2013,34(3):205-209.

[12]ZHU JY,YAN YM,MA DR.Analysis infection module in families by carrying HBV[J].Prev Med Trib,2006,12(2):148-150.(in Chinese)朱建勇,严玉明,马道瑞.卫辉市部分乙肝感染者家庭的感染模式分析[J].预防医学论坛,2006,12(2):148-150.

[13]POURNIK O,ALAVIAN SM,GHALICHI L,et al.Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis Dcoinfection:a data-mining approach[J].Hepat Mon,2013,13(5):e7652.

Relative Articles

[1]	Bingqi MA, Huijuan MENG, Wei ZHANG, Xiaofeng DONG, Meng WANG, Jie DOU, Yuning WU, Shiping LI. Prognostic value of several immune and inflammatory indices after curative-intent resection for intrahepatic cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2022, 38(9): 2061-2066. doi: 10.3969/j.issn.1001-5256.2022.09.021
[2]	Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020
[3]	Weihong LIU, Hui LIU, Huiguo DING, Lei LI. Clinical characteristics and prognosis of patients with chronic hepatitis B combined with metabolic associated fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(10): 2230-2235. doi: 10.3969/j.issn.1001-5256.2022.10.007
[4]	Xiaobin CHEN, Jiaqi YUAN, Zhixin WANG, Haining FAN, Zhaojun XU, Xuepeng MEI, Haijiu WANG, Jiamin MA, Ying ZHOU, Lizhao HOU. Correlation between systemic immune-inflammation index and prognosis in patients with hepatic alveolar echinococcosis[J]. Journal of Clinical Hepatology, 2021, 37(2): 375-379. doi: 10.3969/j.issn.1001-5256.2021.02.025
[5]	Lin CHEN, Ning LIU, Jinglan JIN, Yanjun CAI, Fang XU, Junqi NIU, Wanyu LI. Research status and challenges in the prognosis of primary biliary cholangitis after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(4): 955-958. doi: 10.3969/j.issn.1001-5256.2021.04.050
[6]	Yan YongFeng, Jiang Xin, Zhong Rui, Xu Huan, Peng Yan, Tang XiaoWei. Clinical features and prognosis of acute pancreatitis with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(5): 1091-1096. doi: 10.3969/j.issn.1001-5256.2020.05.028
[7]	JIANG Xin, YAN YongFeng, ZHONG Rui, XU Huan, PENG Yan, TANG XiaoWei. Influence of serum triglyceride level on the prognosis of acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(11): 2509-2514. doi: 10.3969/j.issn.1001-5256.2020.11.022
[8]	Dang FuTao, Tang YingMei. Diagnostic and prognostic value of autoantibodies in primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(5): 1164-1166. doi: 10.3969/j.issn.1001-5256.2020.05.048
[9]	Luo Qiong, Wang ChunMing, Liao HangYu, Chen KunLing, Pan MingXin. Value of the NDRG family in the diagnosis and prognostic evaluation of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(6): 1284-1288. doi: 10.3969/j.issn.1001-5256.2020.06.019
[10]	Xu Li, Zheng YueQi, Shi Zhen, Chen YiYun, Shao HuiJiang, Chen JianJie. Influencing factors for the prognosis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1870-1873. doi: 10.3969/j.issn.1001-5256.2019.08.050
[11]	Zhao DanTong, Yan HuiPing, Liu YanMin, Huang ChunYang, Zhang HaiPing, Zhao Yan, Liao HuiYu. Clinical features and prognosis of patients with primary biliary cholangitis complicated by hepatitis virus infection[J]. Journal of Clinical Hepatology, 2017, 33(8): 1532-1536. doi: 10.3969/j.issn.1001-5256.2017.08.025
[12]	Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022
[13]	Huang ChunYang, Liu YanMin. Prognostic evaluation of primary biliary cirrhosis and its value in guiding therapeutic regimens[J]. Journal of Clinical Hepatology, 2016, 32(7): 1266-1272. doi: 10.3969/j.issn.1001-5256.2016.07.009
[14]	Cui YanPing, Li QingFang, Li QingYan, Liu ChunHua, Wang WeiHong, Yuan JianGuo, Wang SiKui. Logistic regression analysis of prognostic risk factors for hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(1): 135-138. doi: 10.3969/j.issn.1001-5256.2016.01.026
[15]	Gao Na, Wu RuiHong, Wang XiaoMei, Niu JunQi. Value of HBsAg quantification in predicting the prognosis of patients with chronic severe hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(4): 695-699. doi: 10.3969/j.issn.1001-5256.2016.04.017
[16]	Zhao DanTong, Liao HuiYu, Liu YanMin, Huang ChunYang, Zhang HaiPing, Sun LiMei, Ma YinXue, Zhao Yan, Yan HuiPing. ROC analysis of prognostic factors in Chinese patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(1): 62-66. doi: 10.3969/j.issn.1001-5256.2014.01.017
[17]	Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155.
[18]	Yu ZeRong, Yuan ChengMin, Yang Bo. A retrospective study on prognostic factors of HBV-related acute-on-chronic liver failure with Qi-deficiency and blood-stasis jaundice [J]. Journal of Clinical Hepatology, 2012, 28(10): 760-763.
[19]	Tang ZhangHua, Li ZhiBin, Liu Fang, Xu DeCui. Comparison of four scoring models in predicting short-term prognosis of chronic severe hepatitis B patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 591-593.

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	刘翠平，肖二辉，毛重山，康谊，尚佳. 慢性乙肝并发EB病毒感染病例肝功能及预后. 中华医院感染学杂志. 2021(07): 1019-1023 .
2.	张秋芬，陈红梅，操金红，胡晓燕. 金华市磐安县体检人群HBV感染、免疫状况及相关危险因素分析. 实用预防医学. 2019(06): 749-751 .
3.	陈海燕. 江苏如皋地区肝硬化病因及疾病进展影响因素分析. 临床军医杂志. 2019(08): 828-829+832 .
4.	张晖汉，张有成，王哲元. RNAi沉默Galectin-1基因对HePG_2肝癌细胞增殖、凋亡的影响. 医学研究杂志. 2019(09): 151-155 .
5.	刘西洋，党思捷，李白雪，吴文军，吴曦，文莉，苏悦，万亭君，冯全生. 家族聚集性慢性HBV感染肾阳虚证与HLA-DQ/HLA-DR/HLA-DP基因多态性的关联研究. 中华中医药杂志. 2018(05): 1984-1987 .
6.	徐龙，吴敏，邹鲁，朱龙川，范声春，张伟，徐贞秋. 江西部分地区慢性HBV感染的家族聚集性分析. 江西医药. 2017(09): 831-832+843 .

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2050) PDF downloads(422)

Familial aggregation and clinical prognosis of hepatitis B virus infection in Guangzhou,China

DOI: 10.3969/j.issn.1001-5256.2016.07.018